COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 840: Articles 8391-8400  | Next

A Novel Y-Shaped, S-O-N-O-S-Bridged Crosslink between Three Residues C22, C44, and K61 Is a Redox Switch of the SARS-CoV-2 Main Protease
Yang, K. S., Kuo, S.-T. A., Blankenship, L. R., Sheng, Y. J., Sankaran, B., Li, P., Fierkee, C. A., Russell, D. H., Yan, X., Xu, S., Liu, W. R.
10.1101/2022.04.29.490044 — Posted: 2022-04-29
Clinical Features and Outcomes of COVID-19 at a Teaching Hospital in Kingston, Jamaica
Thompson, T. K., Dawkins, Y., Rowe-Gardener, S., Chin-Harty, L., Hoe, K. K., Ehikhametalor, K., Ferguson, T. S., Gordon-Johnson, K.-A., Deyde, V.
10.1101/2022.04.27.22274270 — Posted: 2022-04-29
Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination
Carazo, S., Skowronski, D. M., Brisson, M., Sauvageau, C., Brousseau, N., Gilca, R., Ouakki, M., Barkati, S., Fafard, J., Talbot, D., Gilca, V., Deceuninck, G., Garenc, C., Carignan, A., De Wals, P., De Serres, G.
10.1101/2022.04.29.22274455 — Posted: 2022-04-29
Understanding Definitions and Reporting of Deaths Attributed to COVID-19 in the UK - Evidence from FOI Requests
Jefferson, T., Dietrich, M., Brassey, J., Heneghan, C.
10.1101/2022.04.28.22274344 — Posted: 2022-04-29
A Solution to the Kermack and McKendrick Integro-Differential Equations
Duclos, T. G., Reichert, T. A.
10.1101/2022.04.28.22274442 — Posted: 2022-04-29
Mortality among healthcare workers in Indonesia during 18 months of COVID-19
Ekawati, L. L., Arif, A., Hidayana, I., Nurhasim, A., Munziri, M. Z., Lestari, K. D., Tan, A., Ferdiansyah, F., Nashiruddin, F., Adnani, Q. E. S., Malik, H., Maharani, T., Riza, A., Pasaribu, M., Abidin, K., Andrianto, A. A., Nursalam, N., Suhardiningsih, A. V. S., Jubaedah, A., Widodo, N. S., Surendra, H., Sudoyo, H., Smith, A. D., Kreager, P., Baird, J. K., Elyazar, I. R. F.
10.1101/2022.04.27.22274334 — Posted: 2022-04-28
A Pan-Coronavirus Vaccine Candidate: Nine Amino Acid Substitutions in the ORF1ab Gene Attenuate 99% of 365 Unique Coronaviruses: A Comparative Effectiveness Research Study
Luellen, E.
10.1101/2022.04.28.489618 — Posted: 2022-04-28
CLINICAL MANIFESTATIONS AND DIAGNOSIS OF CO-INFECTION OF COVID-19, TUBERCULOSIS AND OPPORTUNISTIC PULMONARY INFECTIONS IN LATE-STAGE HIV PATIENTS WITH IMMUNODEFICIENCY
Mishina, A. V., Mishin, V. Y., Shashenkov, I. V.
10.1101/2022.04.26.22274235 — Posted: 2022-04-28
The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype
Barut, T., Halwe, N. J., Taddeo, A., Kelly, J. N., Schön, J., Ebert, N., Ulrich, L., Devisme, C., Steiner, S., Trueeb, B. S., Hoffmann, B., Veiga, I. B., Leborgne, N. F. G., Moreira, E. A., Breithaupt, A., Wylezich, C., Höper, D., Wernike, K., Godel, A., Thomann, L., Flück, V., Stalder, H., Brügger, M., Esteves, B. I. O., Zumkehr, B., Beilleau, G., Kratzel, A., Schmied, K., Ochsenbein, S., Lang, R. M., Wider, M., Machahua, C., Dorn, P., Marti, T. M., Funke-Chambour, M., Rauch, A., Widera, M., Ciesek, S., Dijkman, R., Hoffmann, D., Alves, M. P., Benarafa, C., Beer, M., Thiel, V.
10.1101/2022.04.28.489537 — Posted: 2022-04-28
Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike
Zhang, J., Weichun, T., Gao, H., Lavine, C., Shi, W., Peng, H., Zhu, H., Anand, K., Kosikova, M., Kwon, H. J., Tong, P., Gautam, A., Rits-Volloch, S., Wang, S., Mayer, M. L., Wesemann, D., Seaman, M. S., Lu, J., Xiao, T., Xie, H., Chen, B.
10.1101/2022.04.28.489772 — Posted: 2022-04-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).